Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Julphar
Harvard Business School
McKesson
Baxter
Queensland Health
Healthtrust
Boehringer Ingelheim
Teva
Deloitte

Generated: October 21, 2017

DrugPatentWatch Database Preview

FENTANYL-100 Drug Profile

« Back to Dashboard

Which patents cover Fentanyl-100, and what generic Fentanyl-100 alternatives are available?

Fentanyl-100 is a drug marketed by Actavis Labs Ut Inc, Aveva, Lavipharm Labs, Mallinckrodt Inc, Mylan Technologies, Mayne Pharma, Noven, and 3m Drug Delivery. and is included in eight NDAs.

The generic ingredient in FENTANYL-100 is fentanyl. There are thirty-one drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the fentanyl profile page.

Summary for Tradename: FENTANYL-100

US Patents:0
Applicants:8
NDAs:8
Suppliers / Packagers: see list20
Bulk Api Vendors: see list20
Clinical Trials: see list7,632
Patent Applications: see list6,857
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FENTANYL-100 at DailyMed

Pharmacology for Tradename: FENTANYL-100

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut Inc
FENTANYL-100
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL076709-004Aug 20, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Noven
FENTANYL-100
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL077775-004Oct 16, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt Inc
FENTANYL-100
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL077154-004Feb 9, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
3m Drug Delivery
FENTANYL-100
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL202097-005Nov 4, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Aveva
FENTANYL-100
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL077449-004Oct 20, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Lavipharm Labs
FENTANYL-100
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL077051-004Aug 4, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma
FENTANYL-100
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL077062-004Aug 20, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Technologies
FENTANYL-100
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL076258-004Jan 28, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Merck
McKesson
Baxter
US Army
Express Scripts
Chinese Patent Office
Harvard Business School
Novartis
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot